PROFUSA, INC. Increase (Decrease) in Deferred Liabilities
PROFUSA, INC. (PFSA) reported Increase (Decrease) in Deferred Liabilities of -$23.28 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2024-02-26
- PROFUSA, INC. increase (decrease) in deferred liabilities for the quarter ending 2023-12-31 was $13.66K.
- PROFUSA, INC. increase (decrease) in deferred liabilities for fiscal 2023 was -$23.28K, a 163.02% decline from fiscal 2022.
- PROFUSA, INC. increase (decrease) in deferred liabilities for fiscal 2022 was $36.94K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|
| 2023-12-31 | $13.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$23.28K 10-K · filed 2024-02-26 | |
| 2023-09-30 | -$36.94K 10-Q · filed 2023-11-20 | ||
| 2022-12-31 | $36.94K 10-K · filed 2024-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |